Meet a Scientist
Francesca Marassi, Ph.D.
Professor, Cancer Metabolism and Signaling Networks Program
Our path starts here
Join us on our journey as we drive scientific research to improve patient treatments for tomorrow.
Cancer
The Institute’s Cancer Center is one of only seven NCI-designated basic cancer research centers in the nation. We couple fundamental biological research with early translational studies to find new, innovative therapies that restore hope to cancer patients and their families.
Meet a Scientist
Garth Powis, D. Phil.
Jeanne and Gary Herberger Leadership Chair in Cancer Research
Neuroscience and Aging
Diseases associated with aging and development are already a leading cause of death and disability, and their prevalence is rising fast—to give one example, by 2050, the number of Alzheimer’s patients age 65 and older may nearly triple from 5 million to 13.8 million.
Meet a Scientist
Rolf Bodmer, Ph.D.
Director and Professor, Development, Aging and Regeneration Program
Meet a Scientist
Huaxi Xu, Ph.D.
Jeanne and Gary Herberger Leadership Chair in Neuroscience Research
Immunity
The human immune system is made up of a network of cells, tissues and organs that fight off disease. It can also turn against the body causing autoimmune disorders, such as rheumatoid arthritis, lupus, Crohn’s disease and psoriasis. Increasingly, scientists are learning how to help the body’s immune system to combat cancer.
Meet a Scientist
Adam Godzik, Ph.D.
Adjunct Professor, Cancer Metabolism and Signaling Networks Program
Sanford Children's Health Research Center
Genetic diseases in children are rare, and often incurable. Research insights into the genes and environmental factors that play a role in the development of childhood diseases are leading to better ways to more accurately diagnose, treat and cure children with disease.
Meet a Scientist
Duc Dong, Ph.D.
Associate Dean of Admissions, Graduate School of Biomedical Sciences
Cancer
The Institute’s Cancer Center is one of only seven NCI-designated basic cancer research centers in the nation. We couple fundamental biological research with early translational studies to find new, innovative therapies that restore hope to cancer patients and their families.
Meet a Scientist
Garth Powis, D. Phil.
Jeanne and Gary Herberger Leadership Chair in Cancer Research
Meet a Scientist
Francesca Marassi, Ph.D.
Professor, Cancer Metabolism and Signaling Networks Program
Neuroscience and Aging
Diseases associated with aging and development are already a leading cause of death and disability, and their prevalence is rising fast—to give one example, by 2050, the number of Alzheimer’s patients age 65 and older may nearly triple from 5 million to 13.8 million.
Meet a Scientist
Huaxi Xu, Ph.D.
Jeanne and Gary Herberger Leadership Chair in Neuroscience Research
Meet a Scientist
Rolf Bodmer, Ph.D.
Director and Professor, Development, Aging and Regeneration Program
Immunity
The human immune system is made up of a network of cells, tissues and organs that fight off disease. It can also turn against the body causing autoimmune disorders, such as rheumatoid arthritis, lupus, Crohn’s disease and psoriasis. Increasingly, scientists are learning how to help the body’s immune system to combat cancer.
Meet a Scientist
Adam Godzik, Ph.D.
Adjunct Professor, Cancer Metabolism and Signaling Networks Program
Sanford Children's Health Research Center
Genetic diseases in children are rare, and often incurable. Research insights into the genes and environmental factors that play a role in the development of childhood diseases are leading to better ways to more accurately diagnose, treat and cure children with disease.
Meet a Scientist
Duc Dong, Ph.D.
Associate Dean of Admissions, Graduate School of Biomedical Sciences
Drug Discovery and Technology
SBP has the talent and resources to accelerate the development of new therapeutics.
Prebys Center
Through development and application of modern drug discovery technologies, SBP is uniquely positioned to make next-generation medicines.
Shared Resources
Our cores provide advanced technology, expertise and instrumentation to investigators.
Other Platforms
SBP innovates and maintains key technologies and partnerships to facilitate research.
Prebys Center
Through development and application of modern drug discovery technologies, SBP is uniquely positioned to make next-generation medicines.
Shared Resources
Our cores provide advanced technology, expertise and instrumentation to investigators.
Other Platforms
SBP innovates and maintains key technologies and partnerships to facilitate research.
Beaker Blog September 13, 2019
Sanford Burnham Prebys awarded Padres Pedal the Cause grants to advance cancer research
Read more
Press Release
September 11, 2019
Solving long-sought protein structure opens new avenues for treating disease
Beaker Blog September 10, 2019
How your DNA takes shape makes a big difference in your health
Read more
Paper of the Week
Transcription Factor-Directed Re-wiring of Chromatin Architecture for Somatic Cell Nuclear Reprogramming toward trans-Differentiation
In the News
August 27, 2019
No cure yet, but progress made in managing and detecting Alzheimer’s
Beaker Blog August 23, 2019
Sanford Burnham Prebys scientist receives NIH grant to boost heart muscle
Read more
Beaker Blog August 22, 2019
Fleet Science Center cancer series kicks off with lung cancer discussion
Read more
Press Release
August 19, 2019
$4.96 million CIRM grant awarded to Sanford Burnham Prebys to help the tiniest patients
Press Release
August 14, 2019
Sanford Burnham Prebys expands collaboration with Lilly to investigate immunological therapies
Events
5.7m
5.7 million Americans are living with Alzheimer’s. By 2050, this number is projected to rise to nearly 14 million. SBP research hopes to change that.
Support us
Your support is vital to accelerating scientific discoveries to improve human health.